Nomura Holdings Valuation

Is NMR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NMR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NMR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NMR's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NMR?

Key metric: As NMR is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NMR. This is calculated by dividing NMR's market cap by their current earnings.
What is NMR's PE Ratio?
PE Ratio	10x
Earnings	JP¥274.63b
Market Cap	JP¥2.75t

NMR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	17.9x

Price to Earnings Ratio vs Peers

How does NMR's PE Ratio compare to its peers?

The above table shows the PE ratio for NMR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16.2x
6881 China Galaxy Securities	9.7x	9.8%	HK$143.1b
LPLA LPL Financial Holdings	24.3x	13.5%	US$24.2b
601688 Huatai Securities	10.4x	2.7%	CN¥147.2b
FUTU Futu Holdings	20.3x	22.6%	US$11.7b
NMR Nomura Holdings	10x	0.6%	AR$2.7t

Price-To-Earnings vs Peers: NMR is good value based on its Price-To-Earnings Ratio (10x) compared to the peer average (16.2x).

Price to Earnings Ratio vs Industry

How does NMR's PE Ratio compare vs other companies in the South American Capital Markets Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: NMR is expensive based on its Price-To-Earnings Ratio (10x) compared to the South American Capital Markets industry average (9.6x).

Price to Earnings Ratio vs Fair Ratio

What is NMR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NMR PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	10x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NMR's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.